About the Company
leading the field in the discovery of drugs that modulate the effects of cortisol the adverse effects of excess cortisol have been corcept’s focus since the company’s inception. abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol. in addition to our work with mifepristone, we have developed over 300 proprietary molecules, advancing the most promising of these to the clinic to see if they can mitigate the effects of excess cortisol and the serious, sometimes life-threatening conditions that may result. all of these compounds competitively block the glucocorticoid receptor (gr), but not the progesterone receptor. scientific literature suggests that competitive gr antagonism may have a role in treating many conditions, including post-traumatic stress disorder, mild cognitive impairment, alzheimer’s disease, alcoholis
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CORT News
Corcept Therapeutics (NASDAQ: CORT)
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and ...
Corcept Therapeutics files patent for treatment of neuroepithelial tumors with non-steroidal SGRA
Discover a groundbreaking method to treat GR+ neuroepithelial tumors with Corcept Therapeutics Inc.'s patented non-steroidal SGRA treatment. Learn more about this innovative approach today!
Corcept Therapeutics Inc
Are Financial Advisors Worth It? Beyond stock picking, today's advisors help clients plan for a wide range of financial and life goals.
Corcept: Q4 Earnings Snapshot
MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter earnings of $31.1 million. On a per-share basis, the Menlo Park ...
Corcept Therapeutics Inc CORT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Corcept Therapeutics Inc HTD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...